| Typicality: | 0.325 |
| Saliency: | 0.176 |
| at patient level | 2 | other |
| trial → evaluate → cost-effectiveness | 6 |
| trial → assess → cost-effectiveness | 3 |
| negative | neutral | positive |
| 0.027 | 0.802 | 0.171 |
| Raw frequency | 9 |
| Normalized frequency | 0.176 |
| Modifier score | 0.500 |
| Perplexity | 144.499 |